| Med Surg Eye Care Inc | |
|
22 Mallard Ct, Beckley, WV 25801-3615 | |
| (304) 252-4216 | |
| (304) 253-6809 |
| Full Name | Med Surg Eye Care Inc |
|---|---|
| Type | Facility |
| Speciality | Durable Medical Equipment & Medical Supplies |
| Location | 22 Mallard Ct, Beckley, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134543457 | NPI | - | NPPES |
| 1437241346 | Other | WV | NPI |
| 7169950001 | Other | WV | DMERC, PTAN |
| 1841345000 | Medicaid | WV | |
| SA4049742 | Other | WV | MEDICARE PROVIDER NUMBER |
| Provider Name | Taoufik A Sadat |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1437241346 PECOS PAC ID: 6709882731 Enrollment ID: I20080627000320 |
News Archive
Advanced Instruments, Inc., a leader in laboratory instrumentation, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its GloCyte Automated Cell Counter System and GloCyte Low and High Level Controls.
Niteo Partners, an NEC company, today announced SmartPredict™ Healthcare – the latest iteration of Niteo's award-winning SmartPredict solutions. SmartPredict Healthcare brings cutting edge performance dashboards, data integration and predictive analytics to the healthcare industry in order to improve patient satisfaction, track meaningful use compliance metrics, and improve operational outcomes.
A team of researchers led by Dr. Matt Lewin of the California Academy of Sciences, in collaboration with the Department of Anesthesia at the University of California, San Francisco, has pioneered a novel approach to treating venomous snakebites-administering antiparalytics topically via a nasal spray.
New Hampshire Public Radio: A bill in the state legislature would create an annual public report that details the causes of rising health spending by analyzing now-private information that doctors, hospitals and other health organizations would have to provide to the state's Department of Insurance. The move is partly in response to conflicting narratives: The state's health spending continues to rise, yet hospitals and doctors say they are struggling (Grant, 2/17).
Ruthigen Inc., a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Med Surg Eye Care Inc Po Box 172, Stanaford, WV 25927-0172 Ph: (304) 252-4216 | Med Surg Eye Care Inc 22 Mallard Ct, Beckley, WV 25801-3615 Ph: (304) 252-4216 |
News Archive
Advanced Instruments, Inc., a leader in laboratory instrumentation, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its GloCyte Automated Cell Counter System and GloCyte Low and High Level Controls.
Niteo Partners, an NEC company, today announced SmartPredict™ Healthcare – the latest iteration of Niteo's award-winning SmartPredict solutions. SmartPredict Healthcare brings cutting edge performance dashboards, data integration and predictive analytics to the healthcare industry in order to improve patient satisfaction, track meaningful use compliance metrics, and improve operational outcomes.
A team of researchers led by Dr. Matt Lewin of the California Academy of Sciences, in collaboration with the Department of Anesthesia at the University of California, San Francisco, has pioneered a novel approach to treating venomous snakebites-administering antiparalytics topically via a nasal spray.
New Hampshire Public Radio: A bill in the state legislature would create an annual public report that details the causes of rising health spending by analyzing now-private information that doctors, hospitals and other health organizations would have to provide to the state's Department of Insurance. The move is partly in response to conflicting narratives: The state's health spending continues to rise, yet hospitals and doctors say they are struggling (Grant, 2/17).
Ruthigen Inc., a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
› Verified 9 days ago